Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Biogen to Buy Reata in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
Hedge Funds Seek to Cut Off $1 Billion Meant for Opioid Victims
Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids. Source link
U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source link
Biogen to Cut Roughly 11% of Workforce
The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link
Dove Maker Unilever Still Raising Prices as Volumes Slip
The consumer-goods giant—a bellwether for the global economy and consumer sentiment—boosted prices to make up for soaring commodities and other costs. Source link
How U.S. Drug Companies Could Tip Europe Into Recession
Swings in Ireland’s pharmaceutical industry, often rooted in tax moves by U.S.-based firms, have outsize impact on European output. Source link
At Startup That Says Its AI Writes Medical Records, Humans Do a Lot of the Work
DeepScribe relies on a team of people to review tech-generated reports, listen to medical conversations and revise the records. Source link
Big Pharma Bets Big on China
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
J&J Revenue Up on Surge in Heart Procedures
Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share. Source link
Tornado Damages Key Pfizer Drugmaking Plant
The plant in Rocky Mount, N.C., produces a quarter of the sterile injectable medicines used by U.S. hospitals. Source link